D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CALL
Texas Capital Bancshares
TCBI
$4.28B
| $702K | ﹤0.01% |
9,900
+1,900
| +24% | +$140K |
|
|
ILPT
3202
Industrial Logistics Properties Trust
ILPT
$601M
| $701K | ﹤0.01% |
+30,321
| New | +$680K |
|
|
UBA
3203
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $701K | ﹤0.01% |
42,055
-73,991
| -64% | -$1.16M |
|
3204
AGNC Investment
AGNC
$12.4B
| $698K | ﹤0.01% |
41,639
-5,808,954
| -99% | -$93.9M |
|
|
BHR
3205
Braemar Hotels & Resorts
BHR
$157M
| $697K | ﹤0.01% |
114,864
-201,930
| -64% | -$1.19M |
|
3206
Costamare
CMRE
$1.89B
| $693K | ﹤0.01% |
72,029
+14,887
| +26% | +$139K |
|
|
CPRX
3207
DELISTED
Catalyst Pharmaceutical
CPRX
| $693K | ﹤0.01% |
150,392
-206,555
| -58% | -$821K |
|
3208
CALL
MGIC Investment
MTG
$6.34B
| $693K | ﹤0.01% |
50,000
| – | – |
|
|
DRNA
3209
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $693K | ﹤0.01% |
27,090
-88,755
| -77% | -$2.27M |
|
3210
Atmos Energy
ATO
$29.7B
| $692K | ﹤0.01% |
7,000
-55,035
| -89% | -$5.01M |
|
3211
ICF International
ICFI
$1.45B
| $692K | ﹤0.01% |
7,913
-5,365
| -40% | -$448K |
|
3212
Universal Health Services
UHS
$9.64B
| $692K | ﹤0.01% |
+5,191
| New | +$688K |
|
3213
Peabody Energy
BTU
$2.81B
| $689K | ﹤0.01% |
225,159
| – | – |
|
3214
Spok Holdings
SPOK
$226M
| $689K | ﹤0.01% |
65,738
-11,605
| -15% | -$133K |
|
|
MIME
3215
DELISTED
Mimecast Limited
MIME
| $689K | ﹤0.01% |
17,139
-41,290
| -71% | -$1.82M |
|
|
STR
3216
DELISTED
Sitio Royalties
STR
| $688K | ﹤0.01% |
38,288
-3,131
| -8% | -$49.7K |
|
3217
Andersons Inc
ANDE
$2.54B
| $686K | ﹤0.01% |
25,040
-38,527
| -61% | -$1.02M |
|
3218
Bridgewater Bancshares
BWB
$575M
| $686K | ﹤0.01% |
42,462
+6,579
| +18% | +$97.1K |
|
3219
PUT
MidCap Financial Investment
MFIC
$790M
| $686K | ﹤0.01% |
50,000
-50,000
| -50% | -$660K |
|
|
EXPR
3220
CALL
DELISTED
Express, Inc.
EXPR
| $684K | ﹤0.01% |
+8,510
| New | +$534K |
|
|
BDSI
3221
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $684K | ﹤0.01% |
174,834
-140,437
| -45% | -$580K |
|
3222
CALL
Silicon Motion
SIMO
$8.29B
| $683K | ﹤0.01% |
+11,500
| New | +$654K |
|
3223
Itaú Unibanco
ITUB
$92.3B
| $680K | ﹤0.01% |
+188,421
| New | +$712K |
|
3224
Philip Morris
PM
$305B
| $676K | ﹤0.01% |
7,622
-83,948
| -92% | -$7.13M |
|
3225
Byline Bancorp
BY
$1.76B
| $674K | ﹤0.01% |
31,844
+11,066
| +53% | +$207K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.